Susan L. Solomon

{{Short description|American executive and lawyer (1951–2022)}}

{{Use American English|date=September 2022}}

{{Use mdy dates|date=September 2022}}

{{Infobox_person

| image = Susan L. Solomon Philanthropy Summit 2016 00.47.jpg

| caption = Solomon speaking in 2016

| birth_date = August 23, 1951

| birth_place = Brooklyn, New York City, New York, U.S.

| death_date = September 8, 2022 (age 71)

| death_place = Amagansett, New York, US

| education = New York University (BA)
Rutgers University (JD)

}}

Susan Lynn Solomon (August 23, 1951 – September 8, 2022) was an American executive and lawyer. She was the chief executive officer and co-founder of the New York Stem Cell Foundation (NYSCF).{{cite web|title=Susan L. Solomon (Chief Executive Officer)|url=http://nyscf.org/about-us/board-of-directors/item/228-susan-l-solomon-chief-executive-officer|work=The New York Stem Cell Foundation|accessdate=February 7, 2013|archive-date=March 11, 2014|archive-url=https://web.archive.org/web/20140311121646/http://www.nyscf.org/about-us/board-of-directors/item/228-susan-l-solomon-chief-executive-officer|url-status=live}}

Early life and education

Solomon was born in Brooklyn on August 23, 1951.{{cite news|title=Susan L. Solomon, Crusader for Stem Cell Research, Dies at 71|url=https://www.nytimes.com/2022/09/13/health/susan-l-solomon-dead.html|first=Sam|last=Roberts|date=September 13, 2022|access-date=September 13, 2022|newspaper=The New York Times|archive-date=September 13, 2022|archive-url=https://web.archive.org/web/20220913170443/https://www.nytimes.com/2022/09/13/health/susan-l-solomon-dead.html|url-status=live}} Her father, Seymour Solomon, was the co-founder of Vanguard Records alongside his brother, Maynard;{{cite news|last=Sugarman|first=Jacob|title=Susan Solomon|url=http://flattmag.com/susan-solomon/|accessdate=February 25, 2013|newspaper=Flatt Magazine|date=June 17, 2012|archive-date=July 22, 2012|archive-url=https://web.archive.org/web/20120722181206/http://flattmag.com/susan-solomon/|url-status=live}} her mother, Ruth (Katz), was a pianist and worked as a manager of concert musicians. Solomon attended the Fieldston School. She then studied history at New York University, graduating with a bachelor's degree in 1975. Three years later, she obtained a Juris Doctor from Rutgers University School of Law,{{cite web|title=Susan Solomon & The New York Stem Cell Foundation|url=http://www.newyorksocialdiary.com/node/4359|work=New York Social Diary|accessdate=February 7, 2013|archive-date=August 22, 2013|archive-url=https://web.archive.org/web/20130822172803/http://newyorksocialdiary.com/node/4359|url-status=live}} where she was an editor of the Rutgers Law Review.{{cite web|title=Editorial Board 1977–1978|url=http://rutgerslawreview.com/wp-content/uploads/archive/masthead/7778.pdf|access-date=September 13, 2022|publisher=Rutgers Law Review|archive-date=July 25, 2021|archive-url=https://web.archive.org/web/20210725034952/https://rutgerslawreview.com/wp-content/uploads/archive/masthead/7778.pdf|url-status=live}}

Career

Solomon started her career as an attorney at Debevoise & Plimpton,{{cite web|url=http://www.huffingtonpost.com/susan-l-solomon|title=Susan L. Solomon|work=HuffPost|accessdate=February 7, 2013|archive-date=April 27, 2014|archive-url=https://web.archive.org/web/20140427083519/http://www.huffingtonpost.com/susan-l-solomon|url-status=live}} and worked in the legal profession until 1981. She subsequently held executive positions at MacAndrews & Forbes and APAX (formerly MMG Patricof and Co.). She was the founder and President of Sony Worldwide Networks,{{cite journal|date=August 19, 1996|title=SW's Solomon tapped by Sony|journal=Broadcasting & Cable|volume=126|issue=35|page=43}} the chairman and CEO of Lancit Media Productions, an Emmy award-winning television production company, and then served as the founding CEO of Sotheby's website{{cite news|url=http://partners.nytimes.com/library/tech/99/01/biztech/articles/20sothebys.html|title=Sotheby's Plans Online Auctions|last=Pristin|first=Terry|date=January 20, 1999|newspaper=The New York Times|accessdate=February 25, 2013|archive-date=June 12, 2012|archive-url=https://web.archive.org/web/20120612063453/http://partners.nytimes.com/library/tech/99/01/biztech/articles/20sothebys.html|url-status=live}} prior to founding her own strategic management consulting firm Solomon Partners LLC in 2000.

Solomon was a founding Board member of the Global Alliance for iPSC Therapies (GAiT) and New Yorkers for the Advancement of Medical Research (NYAMR). She served on the Board of the College Diabetes Network{{cite web|url=https://collegediabetesnetwork.org/board|title=CDN Board of Directors {{!}} College Diabetes Network|website=collegediabetesnetwork.org|access-date=October 11, 2019|archive-date=October 11, 2019|archive-url=https://web.archive.org/web/20191011195246/https://collegediabetesnetwork.org/board|url-status=live}} and was a board member for the Centre for Commercialization of Regenerative Medicine.{{cite web |title=Past Board Members |date=November 20, 2020 |url=https://www.ccrm.ca/category/board-of-directors/past-board-members/ |publisher=Centre for Commercialization of Regenerative Medicine |access-date=September 16, 2022}} She also served on the board of directors of the Regional Plan Association of New York,{{cite web|title=Regional Plan Association Mourns Loss of Board Member Susan L. Solomon|url=https://rpa.org/latest/news-release/susan-l-solomon-passing|access-date=September 15, 2022|publisher=Regional Plan Association}} where she was a member of the nominating and governance committee. She previously sat on the strategic planning committee for the Empire State Stem Cell Board.{{cite web|title=Susan Solomon|url=https://collegediabetesnetwork.org/susan-solomon|access-date=September 13, 2022|publisher=College Diabetes Network|archive-date=May 16, 2022|archive-url=https://web.archive.org/web/20220516205352/https://www.collegediabetesnetwork.org/susan-solomon|url-status=live}}

NYSCF

Solomon co-founded NYSCF in 2005. She had earlier started work as a health-care advocate in 1992, when her son was diagnosed with type 1 diabetes.{{cite news|last=Weaver|first=Robin|title=Woman Around Town: Susan Solomon— Passion for a Cause|url=http://www.womanaroundtown.com/locations/new-york/woman-around-town-susan-solomon-passion-for-a-cause|archive-url=https://archive.today/20130412043746/http://www.womanaroundtown.com/locations/new-york/woman-around-town-susan-solomon-passion-for-a-cause|url-status=dead|archive-date=April 12, 2013|accessdate=February 25, 2013|newspaper=Woman Around Town|date=October 25, 2009}} As a result of her son's diagnosis and then her mother's death from cancer in 2004, she sought to find a way in which the most advanced medical research could translate more quickly into cures. In conversations with clinicians and scientists, Solomon identified stem cells as the most promising way to address unmet patient needs.{{Cite journal |doi = 10.2217/rme.12.92|pmid = 23210823|title = The New York Stem Cell Foundation|journal = Regenerative Medicine|volume = 7|issue = 6s|pages = 117–119|year = 2012|last1 = Solomon|first1 = Susan}}

At the time of her death, NYSCF was one of the biggest nonprofits dedicated to stem cell research, employing 45 scientists at their Research Institute in Manhattan and funding an additional 75 scientists around the world.{{cite news|url=https://www.wsj.com/articles/susan-l-solomons-stem-cell-research-quest-1454699397|title=Susan L. Solomon's Stem-Cell Research Quest|last=Wolfe|first=Alexandra|newspaper=The Wall Street Journal|date=February 5, 2016 |language=en-US|access-date=October 11, 2019|archive-date=October 11, 2019|archive-url=https://web.archive.org/web/20191011195245/https://www.wsj.com/articles/susan-l-solomons-stem-cell-research-quest-1454699397|url-status=live}}

Personal life

Solomon married her first husband, Gary Hirsh, in 1968. Together, they had one son. They divorced and she later married Paul Goldberger in 1980. They remained married until her death, and had two children.

Solomon died on September 8, 2022, at her home in Amagansett, New York. She was 71, and suffered from ovarian cancer prior to her death.

Awards

  • Living Landmark Honoree, New York Landmarks Conservancy, 2015{{cite web |url=http://www.nylandmarks.org/events/living_landmarks_gala/honoree_list/ |title=Living Landmarks Celebration: Living Landmarks Honoree List |publisher=The New York Landmarks Conservancy |access-date=October 11, 2019 |archive-date=September 16, 2016 |archive-url=https://web.archive.org/web/20160916013409/http://www.nylandmarks.org/events/living_landmarks_gala/honoree_list/}}
  • Stem Cell Action Leadership Award, Genetics Policy Institute, 2012{{cite web|title=GPI 2012 'Stem Cell Action Award' Honorees Announced|url=http://www.worldstemcellsummit.com/gpi-2012-stem-cell-action-award-honorees-announced|work=World Stem Cell Summit|date=September 18, 2012 |accessdate=February 7, 2013|archive-date=February 9, 2013|archive-url=https://web.archive.org/web/20130209010023/http://www.worldstemcellsummit.com/gpi-2012-stem-cell-action-award-honorees-announced|url-status=live}}
  • New York State Women of Excellence Award 2008
  • Triumph Award, The Brooke Ellison Foundation, 2008{{cite web|title=Susan L. Solomon|date=September 28, 2013 |url=https://www.ccrm.ca/susan-l-solomon/|access-date=September 13, 2022|publisher=Centre for Commercialization of Regenerative Medicine|archive-date=February 17, 2022|archive-url=https://web.archive.org/web/20220217044617/https://www.ccrm.ca/susan-l-solomon/|url-status=live}}

Publications

= Articles =

  • "Institutional Report Cards for Gender Equality: Lessons Learned from Benchmarking Efforts for Women in STEM." Cell Stem Cell (September 9, 2019).{{cite journal|title=Institutional Report Cards for Gender Equality: Lessons Learned from Benchmarking Efforts for Women in STEM|url=https://www.cell.com/cell-stem-cell/pdf/S1934-5909(19)30345-5.pdf|date=September 5, 2019|access-date=September 13, 2022|journal=Cell Stem Cell|doi=10.1016/j.stem.2019.08.010|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114310/https://www.cell.com/cell-stem-cell/pdf/S1934-5909%2819%2930345-5.pdf|url-status=live|last1=Beeler |first1=Whitney H. |last2=Smith-Doody |first2=Kristin A. |last3=Ha |first3=Richard |last4=Aiyar |first4=Raeka S. |last5=Schwarzbach |first5=Elizabeth |last6=Solomon |first6=Susan L. |last7=Jagsi |first7=Reshma |volume=25 |issue=3 |pages=306–310 |pmid=31491394 |s2cid=201869532 }}
  • "Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells." Nature Methods (August 3, 2015).{{cite journal|title=Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells|url=https://www.nature.com/articles/nmeth.3507|date=August 3, 2015|access-date=September 13, 2022|journal=Nature Methods|doi=10.1038/nmeth.3507|archive-date=August 8, 2022|archive-url=https://web.archive.org/web/20220808220013/https://www.nature.com/articles/nmeth.3507|url-status=live|last1=Paull |first1=Daniel |last2=Sevilla |first2=Ana |last3=Zhou |first3=Hongyan |last4=Hahn |first4=Aana Kim |last5=Kim |first5=Hesed |last6=Napolitano |first6=Christopher |last7=Tsankov |first7=Alexander |last8=Shang |first8=Linshan |last9=Krumholz |first9=Katie |last10=Jagadeesan |first10=Premlatha |last11=Woodard |first11=Chris M. |last12=Sun |first12=Bruce |last13=Vilboux |first13=Thierry |last14=Zimmer |first14=Matthew |last15=Forero |first15=Eliana |last16=Moroziewicz |first16=Dorota N. |last17=Martinez |first17=Hector |last18=Malicdan |first18=May Christine V. |last19=Weiss |first19=Keren A. |last20=Vensand |first20=Lauren B. |last21=Dusenberry |first21=Carmen R. |last22=Polus |first22=Hannah |last23=Sy |first23=Karla Therese L. |last24=Kahler |first24=David J. |last25=Gahl |first25=William A. |last26=Solomon |first26=Susan L. |last27=Chang |first27=Stephen |last28=Meissner |first28=Alexander |last29=Eggan |first29=Kevin |last30=Noggle |first30=Scott A. |volume=12 |issue=9 |pages=885–892 |pmid=26237226 |s2cid=9889991 |url-access=subscription }}
  • "Cell Therapy Worldwide: An Incipient Revolution." Regenerative Medicine (March 1, 2015).{{cite journal|title=Cell therapy worldwide: an incipient revolution|url=https://www.futuremedicine.com/doi/10.2217/rme.14.80|date=April 2, 2015|access-date=September 13, 2022|journal=Future Medicine|doi=10.2217/rme.14.80|archive-date=June 1, 2016|archive-url=https://web.archive.org/web/20160601191339/http://www.futuremedicine.com/doi/10.2217/rme.14.80|url-status=live|last1=Rao |first1=Mahendra |last2=Mason |first2=Chris |last3=Solomon |first3=Susan |volume=10 |issue=2 |pages=181–191 |pmid=25835482 |url-access=subscription }}
  • "7 Actionable Strategies For Advancing Women in Science, Engineering, and Medicine." Cell Stem Cell (March 5, 2015).{{cite journal|title=Seven actionable strategies for advancing women in science, engineering, and medicine|volume=16|issue=3|date=March 5, 2015|journal=Cell Stem Cell|doi=10.1016/j.stem.2015.02.012|last1=Smith |first1=Kristin A. |last2=Arlotta |first2=Paola |last3=Watt |first3=Fiona M. |last4=Solomon |first4=Susan L. |last5=Arlotta |first5=Paola |last6=Bargmann |first6=Cori |last7=Berg |first7=David |last8=Briggs |first8=Latese |last9=Chao |first9=Moses V. |last10=Dulac |first10=Catherine |last11=Eggan |first11=Kevin |last12=Escobar-Alvarez |first12=Sindy |last13=Fossati |first13=Valentina |last14=Fuchs |first14=Elaine |last15=Glimcher |first15=Laurie H. |last16=Greco |first16=Valentina |last17=Grosz |first17=Barbara J. |last18=Hsu |first18=Ya-Chieh |last19=Hynes |first19=Mary |last20=Klitzman |first20=Robert |last21=Masur |first21=Sandra |last22=Mummery |first22=Christine |last23=Myers |first23=Betsy |last24=Nirenberg |first24=Melissa J. |last25=Pola |first25=Carolina |last26=Pomeroy |first26=Claire |last27=Ruta |first27=Vanessa |last28=Schachter |first28=Beth |last29=Simmons |first29=Rache |last30=Smith |first30=Kristin A. |pages=221–224 |pmid=25748929 |pmc=4476252 |display-authors=1 }}
  • "Human Oocytes Reprogram Adult Somatic Nuclei to Diploid Pluripotent Stem Cells." Nature (April 28, 2014).{{cite journal|title=Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells|url=https://www.nature.com/articles/nature13287|date=April 28, 2014|access-date=September 13, 2022|journal=Nature|doi=10.1038/nature13287|archive-date=August 9, 2022|archive-url=https://web.archive.org/web/20220809095346/https://www.nature.com/articles/nature13287|url-status=live|last1=Yamada |first1=Mitsutoshi |last2=Johannesson |first2=Bjarki |last3=Sagi |first3=Ido |last4=Burnett |first4=Lisa Cole |last5=Kort |first5=Daniel H. |last6=Prosser |first6=Robert W. |last7=Paull |first7=Daniel |last8=Nestor |first8=Michael W. |last9=Freeby |first9=Matthew |last10=Greenberg |first10=Ellen |last11=Goland |first11=Robin S. |last12=Leibel |first12=Rudolph L. |last13=Solomon |first13=Susan L. |last14=Benvenisty |first14=Nissim |last15=Sauer |first15=Mark V. |last16=Egli |first16=Dieter |volume=510 |issue=7506 |pages=533–536 |pmid=24776804 |bibcode=2014Natur.510..533Y |s2cid=4457834 |url-access=subscription }}
  • "Twenty years of the International Society for Cellular Therapies: the past, present and future of cellular therapy clinical development." Cytotherapy (April 14, 2014).{{cite journal|title=Twenty years of the International Society for Cellular Therapies: the past, present and future of cellular therapy clinical development|url=https://www.isct-cytotherapy.org/article/S1465-3249(14)00005-X/fulltext|volume=16|issue=4|date=April 1, 2014|access-date=September 13, 2022|journal=Cytotherapy|doi=10.1016/j.jcyt.2014.01.001|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114314/https://www.isct-cytotherapy.org/article/S1465-3249%2814%2900005-X/fulltext|url-status=live|last1=Abbott |first1=Stewart |last2=MacKay |first2=Geoff |last3=Durdy |first3=Matthew |last4=Solomon |first4=Susan |last5=Zylberberg |first5=Claudia |pages=S112–S119 |pmid=24629796 |url-access=subscription }}
  • "The New York Stem Cell Foundation. Interview with Susan Solomon." Regenerative Medicine (November 2012).{{cite journal|title=The New York Stem Cell Foundation. Interview with Susan Solomon|url=https://pubmed.ncbi.nlm.nih.gov/23210823/|date=November 2012|access-date=September 13, 2022|journal=Regenerative Medicine|doi=10.2217/rme.12.92|pmid=23210823 |archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914030043/https://pubmed.ncbi.nlm.nih.gov/23210823/|url-status=live|last1=Solomon |first1=S. |volume=7 |issue=6 Suppl |pages=117–119 }}
  • "The New York Stem Cell Foundation: Accelerating Cures Through Stem Cell Research." Stem Cells Translational Medicine (April 2012).{{cite journal|title=The New York Stem Cell Foundation: Accelerating Cures Through Stem Cell Research|date=April 2012|journal=Stem Cells Translational Medicine|doi=10.5966/sctm.2012-0019|pmc=3659693 |last1=Solomon |first1=S. L. |volume=1 |issue=4 |pages=263–265 |pmid=23197805 }}
  • "The sixth annual translational stem cell research conference of the New York Stem Cell Foundation." Annals of the New York Academy of Sciences (May 2012).{{cite journal|title=The Sixth Annual Translational Stem Cell Research Conference of the New York Stem Cell Foundation|url=https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.2012.06481.x|date=March 28, 2012|access-date=September 13, 2022|journal=Annals of the New York Academy of Sciences|doi=10.1111/j.1749-6632.2012.06481.x|last1=Marshall |first1=Caroline |last2=Hua |first2=Haiqing |last3=Shang |first3=Linshan |last4=Ding |first4=Bi-Sen |last5=Zito |first5=Giovanni |last6=De Peppo |first6=Giuseppe Maria |last7=Wang |first7=George Kai |last8=Douvaras |first8=Panagiotis |last9=Sproul |first9=Andrew A. |last10=Paull |first10=Daniel |last11=Fossati |first11=Valentina |last12=Nestor |first12=Michael W. |last13=McKeon |first13=David |last14=Smith |first14=Kristin A. |last15=Solomon |first15=Susan L. |volume=1255 |issue=1 |pages=16–29 |pmid=22458653 |bibcode=2012NYASA1255...16M |hdl=10447/254008 |s2cid=9780628 |hdl-access=free }}

  • Case Comment "Monty Python and the Lanham Act: In Search of the Moral Right." Rutgers Law Review (Winter 1977) 3(2).{{cite journal|title=Monty Python and the Lanham Act: In Search of the Moral Right|url=https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.2012.06481.x|volume=30|issue=2|first=Susan L.|last=Solomon|year=1976|access-date=September 13, 2022|journal=Annals of the New York Academy of Sciences|pages=16–29 |doi=10.1111/j.1749-6632.2012.06481.x|pmid=22458653 |bibcode=2012NYASA1255...16M |hdl=10447/254008 |s2cid=9780628 |hdl-access=free}}

= Editorials =

  • "Raising the Standards of Stem Cell Line Quality." Nature Cell Biology (March 31, 2016).{{cite journal|title=Raising the standards of stem cell line quality|url=https://www.nature.com/articles/ncb3313|date=February 25, 2016|access-date=September 13, 2022|journal=Nature Cell Biology|doi=10.1038/ncb3313|archive-date=June 16, 2022|archive-url=https://web.archive.org/web/20220616035356/https://www.nature.com/articles/ncb3313|url-status=live|last1=Yaffe |first1=Michael P. |last2=Noggle |first2=Scott A. |last3=Solomon |first3=Susan L. |volume=18 |issue=3 |pages=236–237 |pmid=26911906 |s2cid=1710568 |url-access=subscription }}
  • "Banking on iPSC—Is it Doable and is it Worthwhile". Stem Cell Research and Reviews (December 17, 2014).{{cite journal|title=Banking on iPSC—Is it Doable and is it Worthwhile|date=February 2015|journal=Stem Cell Reviews and Reports|doi=10.1007/s12015-014-9574-4|pmc=4333229 |last1=Solomon |first1=S. |last2=Pitossi |first2=F. |last3=Rao |first3=M. S. |volume=11 |issue=1 |pages=1–10 |pmid=25516409 }}
  • "#StemCells: Education, Innovation, and Outreach." Cell Stem Cell: Voices (November 7, 2013).{{cite journal|title=#StemCells: Education, Innovation, and Outreach|url=https://www.cell.com/cell-stem-cell/pdf/S1934-5909(13)00460-8.pdf|date=November 7, 2013|access-date=September 13, 2022|journal=Cell Stem Cell|volume=13 |issue=5 |pages=517–519 |doi=10.1016/j.stem.2013.10.014|pmid=24367811 |archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114312/https://www.cell.com/cell-stem-cell/pdf/S1934-5909%2813%2900460-8.pdf|url-status=live}}
  • "The New Nonprofit: A Model for Innovation Across Sectors." Smart Assets: The Philanthropy New York Blog (March 14, 2013).{{cite news|title=The New Nonprofit: A Model for Innovation Across Sectors|url=https://philanthropynewyork.org/news/new-nonprofit-model-innovation-across-sectors-0|first=Susan L.|last=Solomon|date=March 14, 2013|access-date=September 13, 2022|publisher=Philanthropy New York|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114314/https://philanthropynewyork.org/news/new-nonprofit-model-innovation-across-sectors-0|url-status=live}}
  • "Stem Cell Research: Science, Not Politics." The Huffington Post (September 21, 2010).{{cite news|title=Stem Cell Research: Science, Not Politics|url=https://www.huffpost.com/entry/stem-cell-research-scienc_b_734769|first=Susan L.|last=Solomon|date=September 22, 2010|access-date=September 13, 2022|website=HuffPost|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114315/https://www.huffpost.com/entry/stem-cell-research-scienc_b_734769|url-status=live}}
  • "Opinion: Science Shoved Aside in Stem Cell Ruling." AOL News (August 25, 2010).{{cite news|title=Opinion: Science Shoved Aside in Stem Cell Ruling|url=http://www.aolnews.com/opinion/article/opinion-stem-cell-ruling-puts-politics-ahead-of-science/19606708|first=Susan L.|last=Solomon|date=August 25, 2010|access-date=September 13, 2022|publisher=AOL|archiveurl=https://web.archive.org/web/20101208062148/http://www.aolnews.com/opinion/article/opinion-stem-cell-ruling-puts-politics-ahead-of-science/19606708|archivedate=December 8, 2010|url-status=dead}}
  • "Opportunity for Excellence: The Critical Role of State Programs in the New Federal Landscape." The Huffington Post (June 12, 2009).{{cite news|title=Opportunity for Excellence: The Critical Role of State Programs in the New Federal Landscape|url=https://www.huffpost.com/entry/opportunity-for-excellenc_b_214770|first=Susan L.|last=Solomon|date=July 13, 2009|access-date=September 13, 2022|website=HuffPost|archive-date=May 27, 2020|archive-url=https://web.archive.org/web/20200527092746/https://www.huffpost.com/entry/opportunity-for-excellenc_b_214770|url-status=live}}
  • "Patients Before Politics: Putting Science First." The Huffington Post (March 9, 2009).{{cite news|title=Patients Before Politics: Putting Science First|url=https://www.huffpost.com/entry/patients-before-politics_b_173084|first=Susan L.|last=Solomon|date=April 9, 2009|access-date=September 13, 2022|website=HuffPost|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114316/https://www.huffpost.com/entry/patients-before-politics_b_173084|url-status=live}}
  • "The Stem Cell Wars Are Not Over." The Huffington Post (November 30, 2007).{{cite news|title=The Stem Cell Wars Are Not Over|url=https://www.huffpost.com/entry/the-stem-cell-wars-are-no_b_74802|first=Susan L.|last=Solomon|date=November 30, 2007|access-date=September 13, 2022|website=HuffPost|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114316/https://www.huffpost.com/entry/the-stem-cell-wars-are-no_b_74802|url-status=live}}
  • "After Bush's Veto, What is Next for Stem Cell Research?" The Huffington Post (June 20, 2007).{{cite news|title=After Bush's Veto, What is Next for Stem Cell Research?|url=https://www.huffpost.com/entry/after-bushs-veto-what-is_b_52974|first=Susan L.|last=Solomon|date=June 20, 2007|access-date=September 13, 2022|website=HuffPost|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114320/https://www.huffpost.com/entry/after-bushs-veto-what-is_b_52974|url-status=live}}
  • "Spitzer Shows Leadership in Stem Cell Research." Times Union (February 18, 2007).{{cite news|title=Spitzer shows leadership in stem cell research|url=https://www.proquest.com/docview/266231064|page=E1|first=Susan|last=Solomon|date=February 18, 2007|access-date=September 13, 2022|newspaper=Times Union|location=Albany, New York|id={{ProQuest|266231064}}|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114319/https://www.proquest.com/docview/266231064|url-status=live}}
  • "Today's Stem Cell Bill: A Politically Expedient Approach." The Huffington Post (July 18, 2006).{{cite news|title=Today's Stem Cell Bill: A Politically Expedient Approach|url=https://www.huffpost.com/entry/todays-stem-cell-bill-a-p_b_25330|first=Susan L.|last=Solomon|date=July 18, 2006|access-date=September 13, 2022|website=HuffPost|archive-date=September 14, 2022|archive-url=https://web.archive.org/web/20220914114316/https://www.huffpost.com/entry/todays-stem-cell-bill-a-p_b_25330|url-status=live}}

References